Banner Announcement Take the asssestment
See if I'm eligible

Compounded Medication Disclaimer

Journi Health

Compounded Medication Disclaimer

Important Information About Compounded Drugs Available Through Journi Health

Last updated: June 19, 2026

IMPORTANT: Please read this notice carefully before using any compounded medication available through the Journi Health platform.

What Is a Compounded Medication?

Compounded medications are drugs that are prepared by a licensed compounding pharmacy based on a valid, patient-specific prescription from a licensed healthcare provider. Compounding allows pharmacists to create customized medications tailored to individual patient needs — for example, adjusting dosage forms, strengths, or removing allergens.

Compounded Medications Are NOT FDA-Approved

Compounded medications available through Journi Health are NOT FDA-approved drug products. This means:

  • The U.S. Food and Drug Administration (FDA) does not review compounded medications for safety, effectiveness, or quality before they are dispensed.
  • Compounded drugs are not the same as FDA-approved drugs, which have undergone rigorous review including clinical trials.
  • Compounded drugs are not FDA-approved generic drugs. Generics are distinct FDA-approved products that must demonstrate bioequivalence to the brand-name drug.
  • The FDA has not determined that any compounded medication available through this platform is safe or effective for any use.
Compounded medications are not FDA-approved. They are not FDA-reviewed for safety, effectiveness, or quality. They are not the same as FDA-approved brand-name or generic drugs.

GLP-1 Medications (Semaglutide, Tirzepatide)

If you have been prescribed a compounded GLP-1 medication through Journi Health, the following additional disclosures apply:

  • Compounded semaglutide and tirzepatide are NOT FDA-approved products and are NOT the same as Ozempic®, Wegovy®, Zepbound®, or Mounjaro®, or any other FDA-approved GLP-1 medication.
  • Journi Health does not represent that its compounded GLP-1 products are equivalent, comparable, or identical to any brand-name drug.
  • Long-term safety and efficacy data for compounded GLP-1 formulations have not been established through FDA-reviewed clinical trials.
  • Brand-name equivalents (Ozempic®, Wegovy®, Zepbound®, Mounjaro®) are trademarked products of Novo Nordisk and Eli Lilly. Use of those names on this platform is for informational identification only and does not imply any affiliation, endorsement, or equivalence.

Peptide Therapies

Peptide therapies available through Journi Health are compounded by licensed 503A compounding pharmacies. Unless explicitly stated otherwise:

  • Peptides offered through this platform are not FDA-approved for any medical indication.
  • Any peptide designated as Category 1 or ‘Under Evaluation’ on the FDA’s 503A Bulk Drug Substances list is eligible for compounding under the FDA’s current enforcement discretion policy — this is NOT a finding of safety or efficacy.
  • Journi Health does not offer peptides designated as Category 2 on the FDA’s 503A Bulk Drug Substances list.
  • Regulatory status of individual peptides may change. Consult your provider or contact support@healthjourni.com for current availability.

Prescribing and Dispensing

All prescriptions available through Journi Health are:

  • Written solely by independent licensed healthcare providers who are not employees of Journi Health or Genecis Bio Inc..
  • Dispensed by licensed 503A compounding pharmacies that are independent of Journi Health.
  • Journi Health does not practice medicine, does not prescribe medications, and does not dispense medications.
  • Prescribing decisions are made at the sole discretion of your treating provider. Initiating a consultation or completing an intake form does not guarantee that a prescription will be issued.

Individual Results

Results from compounded medications vary among individuals and are not guaranteed. Journi Health makes no representations about average or typical outcomes. Information on this platform regarding the potential effects of medications is based on published literature about the active ingredient and does not constitute a promise or guarantee of results for compounded formulations.

Risks and Side Effects

All medications, including compounded drugs, carry potential risks and side effects. Your provider will discuss the relevant risks with you during your consultation. Common risks associated with injectable therapies include injection site reactions, nausea, and other adverse effects. You are responsible for reviewing all information provided by your prescribing provider and the dispensing pharmacy before using any medication.

Not a Substitute for In-Person Care

Telehealth services are not appropriate for all medical conditions. If you are experiencing a medical emergency, call 911 immediately. If you have questions about whether a compounded medication is appropriate for you, speak with your treating provider or consult an in-person healthcare professional.

Regulatory References

This disclaimer is consistent with FDA requirements under the Federal Food, Drug, and Cosmetic Act (FDCA), including Sections 503A and 502. For more information about compounded medications, visit: www.fda.gov/drugs/human-drug-compounding.

Questions

If you have questions about a specific compounded medication available through Journi Health, contact our support team:

  • Email: support@healthjourni.com
  • Phone: 1 (866) 525-3777
  • Website: www.healthjourni.com/contact

Journi Health | www.healthjourni.com/compounded-medication-disclaimer | Last updated: June 19, 2026